- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04057066
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis (Feasibility Study)
Internet-based Physical Activity Promotion and Exercise Prescription for People With Multiple Sclerosis. A Feasibility Study.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Due to high inactivity rates in persons with Multiple Sclerosis (pwMS) physical activity promotion for this target group is needed. The internet is an attractive and feasible medium for physical activity promotion, however interventions have to be adapted to the special needs of pwMS. This study aims to evaluate the feasibility of a 12-week internet-based exercise and physical activity counseling intervention.
26 pwMS will be enrolled in the study. All of them receive the intervention. Focus groups and interviews will be conducted with participating pwMS to determine acceptability of the intervention and to explore participants experiences. Compliance with the intervention will be monitored. Additionally, changes in objective physical activity, subjective physical activity, fatigue, walking ability and level of depression will be calculated.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Erlangen, Germany
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
-
-
Baden-Wuerttemberg
-
Bad Wildbad, Baden-Wuerttemberg, Germany, 75323
- Neurological Rehabilitation Center Quellenhof
-
-
Bavaria
-
Würzburg, Bavaria, Germany, 97070
- Klinikum Würzburg Mitte gGmbH
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- diagnosed Multiple Sclerosis (McDonald criteria)
- expanded Disability Status Scale between 0 - 6.5
- neurologically stable (no exacerbation within 30 days prior to enrollment)
- internet access (WiFi)
- basic knowledge on handling personal computer and the internet
- owning a smartphone with the operating system Android or IOS and with access to Google Play Store or Apple App score
- ability to read, write and comprehend as well as communicate electronically
- not regularly physically active (more than 30 minutes twice a week with a moderate intensity (includes aerobic training, resistance training and other sports e.g. Tennis; excludes physiotherapy, physical activity during work or household, grocery shopping, gardening, walking the dog etc.)
Exclusion Criteria:
- clinically relevant cardiovascular diseases
- cortisone therapy in the last 30 days
- cognitive impairment
- severe impairment of hand function (ataxia or paresis impeding the use of a smartphone app or smartwatch)
- severe internal, orthopaedic and metabolic diseases that restrict mobility
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention
Participants receive physical activity counseling as well as an individualized exercise plan.
|
Physical activity counseling consists of two phone or video calls with a therapists, two group video calls with a therapist and a complementary e-learning course.
Participants will agree with their therapist on an exercise plan (endurance and resistance training) that will be made available through the studies mobile app.
Frequency and duration of endurance and strength training shall be prescribed in accordance with exercise guidelines for pwMS.
However, they can be adjusted according to participants prior physical activity level and their available time slots for exercise during the week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Acceptability of the Intervention and participants' experiences (focus groups)
Time Frame: 1 week after the end of the intervention
|
Focus groups (1,5 hrs) with participants to determine extent to which they perceived intervention as appropriate.
|
1 week after the end of the intervention
|
Compliance with intervention protocol (completed training sessions and e-learning modules)
Time Frame: over the 12 weeks of intervention
|
Completed training sessions and e-learning modules will be documented for each participant with the interventions mobile app and e-learning course.
|
over the 12 weeks of intervention
|
Acceptability of the Intervention and participants' experiences (interviews)
Time Frame: 1 week after the end of the intervention
|
With those participants that cannot take part in the focus groups, semistructured interviews (30 min) will be conducted to determine extent to which participants' perceived intervention as appropriate.
Interview questions are based on focus group questions.
The wording is slightly adapted to fit the interview situation.
|
1 week after the end of the intervention
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes in objectively measures physical activity
Time Frame: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
The physical activity level of participants is measured over a 7 day period with the accelerometer Actigraph GT3X+.
The Actigraph GT3X+ measures acceleration on three axes.
Steps per day, physical activity per day (activity counts) and time in moderate and vigorous physical activity per day will be calculated.
|
1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
Changes in subjectively measured physical activity: European Health Interview Survey-Physical Activity Questionnaire (EHIS-PAQ)
Time Frame: 1 week before start of the intervention (T0), 1 week after end of the intervention (T1)
|
8-item questionnaire to assess time spent for work related physical activity, physical activity for transportation (walking, biking), muscle strengthening exercises and sports, fitness or recreational physical activity during a typical week.
|
1 week before start of the intervention (T0), 1 week after end of the intervention (T1)
|
Würzburger Fatigue Inventory for MS (WEIMuS)
Time Frame: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
This questionnaire contains 17 items that form a physical and cognitive subscale.
The total score ranges from zero to a maximum of 68 points (maximum fatigue).
The cut-off value for the presence of fatigue is above 32.
|
1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
Allgemeine Depressionsskala (ADS-L)
Time Frame: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
German version of the Center for Epidemiologic Studies Depression Scale, 20 item questionnaire.
Each item is rated on a 4-point Likert scale.
Answers are scored from 0 to 3. The scores for all items are added up to receive the total score.
The total score ranges from 0 to 60 with higher scores representing higher levels of depression.
|
1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
Multiple Sclerosis Walking Scale-12
Time Frame: 1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
12-item questionnaire measuring self reported walking ability.
Each item is answered on a 5-point Likert scale.
Answers are scored from 1 to 5. The scores for all items are added up to receive a total score.
The total score ranges from 12 to 60 with higher scores representing higher levels of depression.
As a last step the total score is transformed into the walk12-score ranging from 0 to 100 ((total score -12)/48 x 100 = walk12-score).
|
1 week before start of the intervention (T0), 1 week after the end of the intervention (T1)
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Klaus Pfeifer, Prof. Dr., Friedrich-Alexander-Universität Erlangen-Nürnberg, Department of Sport Science and Sport
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- ms bewegt 1.2
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsRecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
University of California, San FranciscoUnited States Department of DefenseRecruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis (MS) | Multiple Sclerosis Relapse | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis Brain Lesion | Multiple Sclerosis BenignUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Queen Mary University of LondonTakeda Pharmaceuticals International, Inc.RecruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited Kingdom
-
Brigham and Women's HospitalMassachusetts General HospitalRecruitingMultiple Sclerosis | Relapsing Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
University of MinnesotaMallinckrodtTerminatedPrimary Progressive Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
Clinical Trials on Physical activity counseling
-
University Hospital Center of MartiniqueClinique Antilles-GuyaneUnknownDiabetes Mellitus, Type 2France
-
Gazi UniversityCompleted
-
The Miriam HospitalBrown UniversityCompleted
-
University of Illinois at Urbana-ChampaignCompletedQuality of Life | Physical Activity | Cognitive Impairment | Cancer of the ProstateUnited States
-
Medipol UniversityActive, not recruiting
-
US Department of Veterans AffairsCompletedObesity | Diabetes | Impaired Glucose ToleranceUnited States
-
University of Sao PauloFundação de Amparo à Pesquisa do Estado de São Paulo; Conselho Nacional de...Completed
-
East Carolina UniversityCompletedQuality of Life | Breast Cancer | Physical ActivityUnited States
-
Hadassah Medical OrganizationActive, not recruitingQuality of Life | Exercise | Obese | Bariatric Surgery | Behavior, HealthIsrael
-
University of WashingtonThe Craig H. Neilsen FoundationCompletedSpinal Cord InjuryUnited States